## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no access to full text, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors report experimental and computational characterization of DNA-binding properties for four Ru(II)-hydrazine complexes, using fluorescence spectroscopy (EtBr displacement), molecular docking, and ONIOM-based QM/MM simulations. They claim all complexes bind DNA with similar strength, that minor groove binding is confirmed for all four, that complex 3 shows the most favorable docking and interaction energies, and that structural substituents modulate DNA affinity and selectivity.
- **Visible evidence base** Abstract text only; specific numerical values for quenching constants, docking scores, and interaction energies are provided
- **Missing materials affecting confidence** Full experimental methods, fluorescence spectra, docking poses, QM/MM model details, statistical analyses, structural characterization data, and any control experiments

## Reviewer
- **Overall assessment** The abstract presents a plausible and potentially interesting study combining experimental and computational approaches to evaluate DNA-binding properties of Ru(II)-hydrazine complexes. However, the evidence provided in the abstract is insufficient to fully assess the validity of the central claims. The correlation between spectroscopic and theoretical results is asserted but not demonstrated with quantitative comparisons. The claim that complex 3 is a "promising candidate" for DNA-targeted therapies is speculative given the limited functional data presented. The work may be of interest to the bioinorganic and medicinal chemistry communities, but the current abstract does not establish the case with sufficient rigor.
- **Who would be interested in the results, and why** Researchers in bioinorganic chemistry, medicinal inorganic chemistry, and DNA-targeted drug design would be interested in the structure-activity relationships of Ru(II)-arene complexes with hydrazine ligands. The combination of experimental and computational methods may appeal to those studying metal-DNA interactions and seeking predictive models for binding affinity.
- **Major strengths** The study integrates multiple complementary techniques (fluorescence spectroscopy, molecular docking, and QM/MM simulations) to address DNA-binding properties. The inclusion of RNA, triplex DNA/RNA, and quadruplex DNA/RNA in docking simulations suggests a broader selectivity assessment. The use of ONIOM-based QM/MM for interaction energy refinement is a sophisticated approach that may provide more reliable energetic estimates than standard docking alone.
- **Major Concerns**  
  - R1-M1  
  - R1-M2  
  - R1-M3  
  - R1-M4
- **Minor Comments**  
  - R1-m1  
  - R1-m2  
  - R1-m3  
  - R1-m4
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3
- **Assessment against Nature-style criteria**  
  - Originality: Moderate. Ru(II)-arene complexes with hydrazine ligands are not entirely novel, but the specific ligand variations and the combined experimental-computational approach may offer incremental novelty.  
  - Scientific importance: Moderate. The findings could inform design of DNA-targeted metal complexes, but the abstract does not demonstrate a significant advance over existing literature.  
  - Interdisciplinary readership: Limited. The work bridges coordination chemistry and computational biology, but the narrow focus on DNA-binding affinity may not attract a broad interdisciplinary audience.  
  - Technical soundness: Not fully assessable from the abstract. The methods are appropriate in principle, but the lack of experimental details and statistical validation prevents verification.  
  - Readability for nonspecialists: The abstract is reasonably clear but uses specialized terminology (e.g., ONIOM, kappa(2)N,N') that may hinder nonspecialist comprehension.
- **Recommendation posture** Currently not established from the provided evidence. The abstract suggests a coherent study, but the central claims require full experimental and computational details to be verified. Supportive if technical concerns are resolved.

### Major Concerns

- **Concern ID** R1-M1  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Evidence sufficiency  
- **Claim pointer** "The results led to the conclusion that all complexes interact with DNA with similar strength"  
- **Evidence pointer** Abstract, fluorescence spectroscopy section  
- **Concern** The claim of similar binding strength is based on quenching constants (K(SV)) ranging from 2.44 to 4.79 x 10(4) M. The abstract does not provide error estimates, replicate numbers, or statistical tests to support the assertion that these values are statistically indistinguishable. The range spans approximately a factor of two, which may or may not be significant depending on experimental variability.  
- **Why it matters** The central conclusion of similar binding affinity across the four complexes underpins the structure-activity discussion. Without statistical validation, the claim is not robust.  
- **Resolution test** Provide mean values with standard deviations, number of independent replicates, and appropriate statistical comparisons (e.g., ANOVA or t-tests) to demonstrate that the K(SV) values are not significantly different.

- **Concern ID** R1-M2  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Claim-evidence alignment  
- **Claim pointer** "Molecular docking confirmed minor groove binding for all four complexes"  
- **Evidence pointer** Abstract, molecular docking section  
- **Concern** The abstract states that docking confirmed minor groove binding, but no docking poses, binding site details, or criteria for "confirmation" are provided. Docking alone typically predicts binding modes, and confirmation requires additional validation (e.g., experimental evidence or comparison with known structures). The term "confirmed" overstates what docking can establish.  
- **Why it matters** The binding mode is a key mechanistic claim. If the docking results are not rigorously validated, the conclusion that all complexes bind in the minor groove is not established.  
- **Resolution test** Provide representative docking poses with clear visualization of the binding site, scoring function details, and a discussion of how the predicted minor groove binding is validated against experimental data or literature precedents.

- **Concern ID** R1-M3  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Quantitative consistency  
- **Claim pointer** "The correlation between spectroscopic and theoretical results highlights the role of Ru(II)-hydrazine ligand structure in modulating DNA affinity"  
- **Evidence pointer** Abstract, correlation statement  
- **Concern** The abstract claims a correlation between experimental (K(SV)) and theoretical (docking scores, QM/MM energies) results, but no quantitative correlation analysis is presented. The K(SV) values range from 2.44 to 4.79 x 10(4) M, while docking scores and interaction energies are reported for complex 3 only. It is unclear whether the theoretical ranking matches the experimental ranking for all four complexes.  
- **Why it matters** The correlation is a central claim that bridges the experimental and computational halves of the study. Without a demonstrated quantitative relationship, the claim is unsupported.  
- **Resolution test** Provide a table or figure comparing K(SV) values, docking scores, and QM/MM interaction energies for all four complexes, along with a correlation coefficient (e.g., Pearson's r) and significance test.

- **Concern ID** R1-M4  
- **Severity** Major  
- **Blocking** No  
- **Axis** Interpretive overreach  
- **Claim pointer** "Complex 3, bearing electron-donating hydrazine functionality and favorable spatial orientation, emerged as a promising candidate for further development in DNA-targeted therapies"  
- **Evidence pointer** Abstract, conclusion  
- **Concern** The designation of complex 3 as a "promising candidate" for DNA-targeted therapies is based solely on in silico and spectroscopic binding data. No cellular assays, toxicity studies, or selectivity against non-DNA targets are presented. The term "promising candidate" implies therapeutic potential that is not supported by the evidence.  
- **Why it matters** Overstating therapeutic relevance may mislead readers and overinterpret the significance of the findings.  
- **Resolution test** Either temper the language to reflect that complex 3 shows the most favorable DNA-binding properties in this study, or provide additional functional data (e.g., cytotoxicity, cellular uptake) to support the therapeutic claim.

### Minor Comments

- **Concern ID** R1-m1  
- **Severity** Minor  
- **Axis** Clarity  
- **Affected element** Complex nomenclature  
- **Evidence pointer** Abstract, first sentence  
- **Issue** The naming of complexes 1-4 is inconsistent. Complex 1 is described as [RuCl(eta(6)-p-cymene)(2)(mu-Cl)(mu-L(1)-kappa(2)N,N')]Cl, while complexes 2-4 are described as [RuCl(2)(eta(6)-p-cymene)(L(1-3)-kappaN)]. The notation "L(1-3)" is ambiguous and does not clearly map to the specific ligands L1, L2, and L3.  
- **Required correction** Clarify the ligand assignments for each complex, e.g., "complex 2 (L1), complex 3 (L2), complex 4 (L3)" with explicit ligand structures.

- **Concern ID** R1-m2  
- **Severity** Minor  
- **Axis** Completeness  
- **Affected element** Selectivity claims  
- **Evidence pointer** Abstract, docking with RNA and quadruplex DNA/RNA  
- **Issue** The abstract states that docking with RNA, triplex DNA/RNA, and quadruplex DNA/RNA "proved that the size of the complex and the presence of substituents were determinants of selectivity." The term "proved" is too strong for computational predictions, and no quantitative selectivity metrics are provided.  
- **Required correction** Replace "proved" with "suggested" or "indicated," and provide numerical selectivity values (e.g., binding energy differences) to support the claim.

- **Concern ID** R1-m3  
- **Severity** Minor  
- **Axis** Methodological transparency  
- **Affected element** QM/MM calculations  
- **Evidence pointer** Abstract, ONIOM-based QM/MM section  
- **Issue** The abstract mentions ONIOM-based QM/MM simulations but does not specify the level of theory for the QM region, the basis sets used, or the partitioning scheme. These details are essential for reproducibility.  
- **Required correction** Include a brief description of the QM level (e.g., DFT functional and basis set) and the MM force field in the abstract or refer to the methods section for full details.

- **Concern ID** R1-m4  
- **Severity** Minor  
- **Axis** Units and notation  
- **Affected element** Quenching constants  
- **Evidence pointer** Abstract, fluorescence spectroscopy section  
- **Issue** The quenching constants are reported as "K(SV)" with units "10(4 )M". The standard notation for Stern-Volmer constants is typically K(SV) with units M(-1). The current notation is unconventional and may confuse readers.  
- **Required correction** Use standard units of M(-1) for K(SV) and ensure consistent formatting throughout.

## Risk / unsupported claims
- The claim that all complexes interact with DNA with "similar strength" is unsupported without statistical analysis of the K(SV) values.
- The claim that molecular docking "confirmed" minor groove binding is unsupported without validation of docking predictions.
- The claimed correlation between spectroscopic and theoretical results is not demonstrated with quantitative data.
- The designation of complex 3 as a "promising candidate for DNA-targeted therapies" is unsupported by functional or cellular data.
- The claim that docking "proved" size and substituents as determinants of selectivity is overstated for computational results.
- The interaction energy for complex 3 (DeltaE = -532.7 kJ mol(-1)) is reported without context or comparison to the other complexes, making its significance unassessable.